Description

BSE lists further securities issued under ESOP/ESOS by 8 companies, effective January 20, 2026, including Axis Bank, CG Power, Cyient, and others.

Summary

BSE has announced the listing and admission for trading of further securities issued under Employee Stock Option Plans (ESOP) and Employee Stock Option Schemes (ESOS) by 8 companies. These securities will be available for trading with effect from Tuesday, January 20, 2026. All listed shares have no lock-in period restrictions.

Key Points

  • 8 companies are listing additional equity shares issued under ESOP/ESOS schemes
  • Total of 570,629 new shares to be listed across all companies
  • All shares will be available for trading from January 20, 2026
  • None of the newly listed shares are subject to any lock-in period
  • Notice issued by BSE on January 19, 2026 (Notice No. 20260119-10)

Company-wise Details

Sr.NoCompany NameISINScrip CodeNo. of SharesFace Value (₹)
1Axis Bank LimitedINE238A0103453221588,1982
2CG Power and Industrial Solutions LimitedINE067A0102950009310,0002
3Cyient LimitedINE136B0102053217512,4425
4Dr. Agarwal’s Health Care LimitedINE943P01029544350337,5041
5Five-Star Business Finance LimitedINE128S0102154366310,7501
6KFin Technologies LimitedINE138Y010105437205,50610
7Sterlite Technologies LimitedINE089C0102953237424,6002
8Tracxn Technologies LimitedINE0HMF0101954363881,6291

Regulatory Changes

No regulatory changes announced. This is a routine administrative notification for sub-listing of securities issued under existing ESOP/ESOS frameworks.

Compliance Requirements

  • Market participants are required to take note of the new securities being listed
  • Trading systems should be updated to reflect the increased share capital for these companies
  • For clarifications, market participants can contact BSE at 022-2272 5271/5878

Important Dates

  • Notice Date: January 19, 2026
  • Listing and Trading Effective Date: January 20, 2026 (Tuesday)
  • Lock-in Period: Not applicable (NA) for all companies

Impact Assessment

Market Impact: Low - The listing of ESOP/ESOS shares represents a marginal increase in the outstanding share capital of these companies. Dr. Agarwal’s Health Care Limited has the largest issuance with 337,504 shares, while the other companies have relatively smaller numbers. Since there is no lock-in period, these shares are immediately tradable, but the volumes are unlikely to significantly impact market liquidity or price discovery for these securities.

Operational Impact: Minimal - This is a routine sub-listing process that exchanges and market participants handle regularly. No special operational adjustments are required beyond standard listing procedures.

Impact Justification

Routine administrative listing of ESOP/ESOS shares with no lock-in period. Limited market impact as the number of shares being listed is relatively small compared to total outstanding shares of these companies.